Elekta

Report Publication Announcement • Nov 11, 2008

INVITATION TO TELEPHONE CONFERENCE

Stockholm, Sweden, November 11, 2008

Elekta's interim report for the second quarter 2008/09 will be published on Thursday, December 4 at around 13.00 CET and a telephone conference will be held the same day at 16.00 CET.

Tomas Puusepp, President and CEO, and Håkan Bergström, CFO, will comment on the six months results and answer questions.

To take part in the conference call, please dial in about five minutes in advance.

Call-in numbers for teleconference, December 4 at 16.00 CET
-------------------------------------------------------------

UK:	+44 (0)20 7162 0025
US:	+1 334 323 6201
Norway:	+47 2156 312 0
France:	+33 (0)1 7099 3208
Germany:	+49 (0)695 8999 0507
Netherlands:	+31 (0)20 7965 008
Sweden:	+46 (0)8 5052 0110
Denmark:	+45 3271 4607
Switzerland (Geneva):	+41 (0)2 2592 7007
Switzerland (Zurich):	+41 (0)434 5692 61

The teleconference will also be broadcasted over the Internet (audio only). Please visit www.elekta.com – Investor Events, or use the direct link: http://wcc.webeventservices.com/view/wl/r.htm?e=117926&s=1&k=B4B7CF61FBA 2C2945A114DF02EDF6264&cb=genesys

The telephone conference will be available afterwards on instant replay for seven days. Please dial UK +44 (0)207 031 40 64, Sweden +46 (0) 8 505 203 33, US +1 954 334 03 42 and use access code 807583.

******

For further information, please contact:

Lena Schattauer, Investor Relations, Elekta AB Tel: +46 8 587 257 22, +46 70 595 51 00, e-mail: lena.schattauer@elekta.com

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.